A Rite Aid Corp. Store Ahead Of Earnings Figures
A pedestrian walks past a Rite Aid Corp. store in New York, U.S., on Wednesday, Dec. 14, 2016. Photographer: Victor J. Blue/Bloomberg via Getty ImagesVictor J. Blue — Bloomberg via Getty Images
  • Previous Rank
  • Revenues ($M)
  • Revenue Percent Change
  • Profits ($M)
  • Profits Percent Change
  • Assets ($M)
  • Employees
  • Market Value — as of March 31, 2017 ($M)

The proposed $9.4 billion merger between Rite Aid and Walgreens faces increasing scrutiny from the Federal Trade Commission. Rite Aid CEO John Standley has criticized what he says is a drawn-out regulatory process but has also admitted that the uncertainty around the deal is taking a hit on the pharmacy and drug store chain's business. In a recent letter to employees, Standley seemed to imply that Rite Aid is mulling how to proceed if the deal falls through.

Company Info

CEOJohn T. Standley
CEO TitleChairman & Chief Executive Officer
SectorFood & Drug Stores
IndustryFood and Drug Stores
HQ LocationCamp Hill, PA
Years on Fortune 500 List23

Key Financials (Last Fiscal Year)

Revenues ($M)$30,737
Profits ($M)$165.5
Assets ($M)$11,277
Total Stockholder Equity ($M)$581
Market Value — as of March 31, 2017 ($M)$4,473

Profit Ratios

Profit as % of Revenues0.5%
Profits as % of Assets1.5%
Profits as % of Stockholder Equity28.5%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)0
EPS % Change (from 2015)-92.3%
EPS % Change (5 year annual rate)-
EPS % Change (10 year annual rate)-21.9%

Total Return

Total Return to Investors (2016)5.1%
Total Return to Investors (5 year, annualized)45.6%
Total Return to Investors (10 year, annualized)4.2%